Second, tumor cells with hyperactive taurine metabolism outcompete immune cells for taurine uptake via transporters such as SLC6A6, inducing endoplasmic reticulum stress and upregulation of inhibitory receptors including PD-1 (17, 28). The gene discussed is SLC6A6; the disease is neoplasm.